- Find a clinical trial
- Amgen 20230153
Lung
Amgen 20230153
A Phase 2 study evaluating efficacy, safety, tolerability and PK of AMG 193 in subjects with metastatic or locally advanced MTAP-deleted NSCLC who have previously received at least one line of treatment.
Trial overview
Medical Oncology
Lung
Lung & bronchus
II
Registration number: NCT06593522
St Leonards (North Shore Health Hub)
North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia
Clinical trials enquiries
Thank you for submitting.
Thank you for submitting.
We will be in touch within 24 hours
Form submission error
An unexpected error has occurred.
You will need to complete the form again, sorry for the inconvenience.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.